ST. PAUL, Minn., Aug. 27, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Dr. Steve Feldman, Scientific Director and Site Head of Stanford Medicine's Laboratory for Cell and Gene Medicine (LCGM), has been awarded the inaugural G-Rex® Grant. Dr. Feldman's $300,000 G-Rex Grant will enable expeditious development of Stanford Medicine's LCGM's G-Rex platform for CAR-T cell therapy manufacturing, which w ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 | --- | --- | |---------------------------------------------------------------------------------------------------------------- ...

SCOTTSDALE, Ariz., Aug. 15, 2024 /PRNewswire/ -- Cyber Enviro-Tech Inc. (CETI) (OTCQB: CETI) is excited to announce that it has entered into an agreement to acquire the land, assets and permits to a Salt Water Disposal (SWD) facility in southern Oklahoma. With access to the necessary licenses, CETI has commenced operations to deploy its advanced oil reclamation technologies. These technologies enable CETI to eliminate Sulphur, Iron Sulfite, and demulsifying agents directly from the oil at any concentration ...

Record second quarter net revenue of $193 million, up 27% year-over-year Record second quarter adjusted EBITDA of $62 million, up 49% year-over-year Record second quarter net income of $45 million, up 52% year-over-year, and record second quarter adjusted net income of $51 million, up 58% year-over-year Record first half net operating cash flow of $105 million and free cash flow of $104 million Announces Ido Bachelet as Chief Science Officer NEW YORK, Aug 7, 2024 /PRNewswire/ -- ODDITY Tech Ltd. (NASDAQ: OD ...

Bio-Techne Corporation (NASDAQ:TECH) Q4 2024 Earnings Conference Call August 7, 2024 9:00 AM ET Company Participants David Clair – Vice President-Investor Relations Kim Kelderman – President and Chief Executive Officer Jim Hippel – Chief Financial Officer Conference Call Participants Puneet Souda – Leerink Partners Jacob Johnson – Stephens Dan Arias – Stifel Dan Leonard – UBS Jack Meehan – Nephron Research Matt Larew – William Blair Catherine Schulte – Baird Justin Bowers – Deutsche Bank Sung Ji Nam – Scoti ...

Techne (TECH) came out with quarterly earnings of $0.49 per share, missing the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -3.92%. A quarter ago, it was expected that this maker of medical testing and diagnostic products would post earnings of $0.46 per share when it actually produced earnings of $0.48, delivering a surprise of 4.35%. Over the ...

Exhibit 99.1 BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS Minneapolis/August 7, 2024/ Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2024. Fourth Quarter FY2024 Highlights ● Fourth quarter organic revenue increased by 1% (2% reported) to $306.1 million. Full year organic revenue increased 1% (2% reported) to $1.2 billion. ● GAAP earnings per share (EPS) was $0.25 versus $0.47 one year ago. Delivered adjusted EPS of $0.49 compared t ...

MINNEAPOLIS, Aug. 7, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2024. The quarterly dividend will be payable August 30, 2024, to all common shareholders of record on August 19, 2024. Future cash dividends will be considered by the Board of Directors on a quarterly basis. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bio ...

MINNEAPOLIS, July 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is pleased to announce the launch of the Leo™ System. This next-generation Simple Western™ instrument offers higher throughput, flexibility, and efficiency over the current Jess™ and Abby™ Simple Western Systems. This stateof-the-art instrument enables simultaneous processing of up to 100 samples in a single 3-hour run, allowing scientists to process more samples in a day. Leo also provides 4-times the experimental size of Jess ...

MINNEAPOLIS, July 29, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced its participation in Spear Bio's $45 million Series A funding round. Spear Bio will use the proceeds from this funding round to further accelerate product development and scale its in-house manufacturing capacity. BioTechne joined Foresite Capital, and other investors, in this funding round. Founded in 2021 and headquartered in Woburn, Massachusetts, Spear Bio is an innovative leader in the development, and manu ...